Medtronic Stock News

AI healthcare stocks can potentially revolutionize patient care as we know it. The groundbreaking technology is expected to have a pervasive impact on the investment world, with its most profound anticipated transformations in healthcare.

The ProShares S&P 500 Dividend Aristocrats ETF slumps to end the first half of 2024, posting a loss of 1.40% in June. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 36 months of tracking these strategies, two strategies are outperforming NOBL, while 1 remains relatively close.

Across industries, companies will need to adopt AI for growth and survival. A PricewaterhouseCoopers indicates that by 2030, AI could contribute up to $15.7 trillion to the global economy.

Blue-chip stocks are known for their stability, but recent investor caution suggests that even these giants aren't immune to scrutiny. Following a rollicking start to the year, the stock market is consolidating.

24/7 Insights The Dividend Aristocrats provide dependable passive income streams.

It's not just big tech stocks that have experienced a pullback lately. Many other highly-followed stocks have as well, including some of blue-chip stocks.

Automation advancements have been incredible, putting the spotlight on the robotics sector as a whole. Indeed, the rise of artificial intelligence has boosted robotics use in manufacturing, healthcare, and e-commerce.

Dividend stocks pay dividends to their shareholders, representing a portion of the company's profits. Not all companies offer dividends.